Identify Fast-Growing Cells Early to Speed Up Cell Line Development
Broadcast date: September 09, 2025On-demand
Nora Fekete-Drimusz
Nora holds a Master's in Bioengineering from Budapest and a Master's in Stem Cells and Regeneration from Bristol, along with a PhD in Regenerative Sciences and an MBA in Business Innovation. This unique blend of scientific expertise and strategic vision makes her an invaluable asset. Since joining Arralyze in 2021, Nora has played a pivotal role in shaping the company's go-to-market strategy, building key collaborations, and ensuring the value of their technology is clearly communicated to both customers and partners.
Close
Robin Krueger
Robin Krüger leads the Life Science division Arralyze at LPKF, where he drives the development of cutting-edge tools for automated single-cell analysis. With a background that spans chemistry, functional materials and life sciences, he brings a uniquely interdisciplinary perspective to the field. Prior to Arralyze, he held various development related roles at LPKF, most recently as Head of Group Innovation from where he spun-out Arralyze. Robin holds a doctoral degree from Philipps University Marburg/Germany and currently splits his time between Hannover, Germany, and Boston, USA.
Close
Discover how to accelerate cell line development by enabling early identification of fast-growing single-cell clones, reducing development timelines from weeks to days.
Learn to identify fast-growing single-cell clones in just three days using CellShepherd®.
Discover how high-resolution nanowell imaging and AI-assisted tracking enhance clone selection accuracy.
Understand how CellShepherd® reduces scale-up time by more than 30% while maintaining stable phenotypic traits.
Explore real-world use cases demonstrating faster, data-driven decisions in cell line development.
Are you ready to improve the way you approach cell line development? Join us for a webinar that introduces Arralyze's CellShepherd®, a platform that might just reshape your workflow.
Traditional methods often leave researchers guessing about which cell clones will thrive. CellShepherd® offers a clearer picture by identifying promising clones much earlier.
We’ll explore how this platform uses high-resolution imaging and AI to classify cells into distinct growth profiles within days. This means you can make informed decisions sooner, potentially shaving weeks off your development time. The system has been tested thoroughly, ensuring that the clones you choose will perform well as they scale up.
If you’re working with therapeutic proteins, monoclonal antibodies, or cultivated meat, this session could provide the insights you need. Expect to see real examples of how CellShepherd® supports quicker and more confident decision-making. Join us to see how you can streamline your cell line development process with a method that’s both innovative and practical.
All emails contain an unsubscribe link.You can review our privacy policy, cookie policy and terms and conditions online.
